Literature DB >> 8591920

Eye movements in schizophrenia.

R D Yee1, R W Baloh, S R Marder, D L Levy, S M Sakala, V Honrubia.   

Abstract

Smooth pursuit and other eye movements were quantitatively studied in patients with chronic schizophrenia to characterize the pattern and severity of eye movement abnormalities in this disorder. Twenty-one patients with schizophrenia, 13 patients with other psychiatric disorders (manic-depressive psychosis, schizoaffective disorder, depression and obsessive-compulsive disorder), and 19 normal subjects were studied. Horizontal eye movements were recorded with DC electro-oculography and analyzed by an online computer system. Eye velocity and closed-loop gain of pursuit, optokinetic nystagmus (OKN), vestibulo-ocular response (VOR) and visual-vestibular interactions were calculated. The latency, accuracy and peak velocity-amplitude relationships of voluntary saccades were measured. The group mean gains of pursuit and OKN of the schizophrenic patients were significantly lower than those of the normal subjects. Suppression of the VOR by fixation was impaired, and the latency of saccades was prolonged. However, the differences in group mean values were small in magnitude, and the frequencies of outliers among the schizophrenic patients were low. The patients with other psychiatric disorders had a similar pattern and severity of eye movement abnormalities. The frequency and severity of eye movement abnormalities in schizophrenic patients are lower than those indicated by previous studies that used different techniques of analysis.

Entities:  

Mesh:

Year:  1987        PMID: 8591920

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Smooth pursuit and saccadic eye movement performance in a prefrontal leukotomy patient.

Authors:  D C Gooding; W G Iacono; D R Hanson
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

2.  Eye tracking dysfunction in families with multiple cases of schizophrenia.

Authors:  V Arolt; R Lencer; A Nolte; M Pinnow; E Schwinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 3.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.

Authors:  Deborah L Levy; Anne B Sereno; Diane C Gooding; Gilllian A O'Driscoll
Journal:  Curr Top Behav Neurosci       Date:  2010

4.  Downbeat nystagmus: characteristics and localization of lesions.

Authors:  R D Yee
Journal:  Trans Am Ophthalmol Soc       Date:  1989

5.  Emotional attention modulates microsaccadic rate and direction.

Authors:  Koji Kashihara; Kazuo Okanoya; Nobuyuki Kawai
Journal:  Psychol Res       Date:  2013-03-28

6.  Dark condition normalization of smooth pursuit tracking: evidence of cerebellar dysfunction in psychosis.

Authors:  R T Pivik; F W Bylsma; P M Cooper
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

7.  The effects of background illumination and stimulant medication on smooth pursuit eye movements of hyperactive children.

Authors:  F W Bylsma; R T Pivik
Journal:  J Abnorm Child Psychol       Date:  1989-02

Review 8.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

9.  Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders.

Authors:  S Ben-Shachar; B Lanpher; J R German; M Qasaymeh; L Potocki; S C Sreenath Nagamani; L M Franco; A Malphrus; G W Bottenfield; J E Spence; S Amato; J A Rousseau; B Moghaddam; C Skinner; S A Skinner; S Bernes; N Armstrong; M Shinawi; P Stankiewicz; A Patel; S-W Cheung; J R Lupski; A L Beaudet; T Sahoo
Journal:  J Med Genet       Date:  2009-03-15       Impact factor: 6.318

10.  Smooth pursuit eye tracking dysfunction in schizophrenia: subcortical implications.

Authors:  R T Pivik
Journal:  J Psychiatry Neurosci       Date:  1991-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.